Improved delivery of the OVA-CD4 peptide to T helper cells by polymeric surface display on Salmonella

Microbial Cell Factories

Volumn 13, Issue 1, 2014, Pages

  Zhang, Junjie ^a,b,c   De Masi, Leon ^b   John, Beena ^b   Chen, Wenxin ^a   Schifferli, Dieter M ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^c ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY   (China)

Author keywords

Autotransporter; MisL; Ovalbumin; Salmonella; T5SS

Indexed keywords

BACTERIAL PROTEIN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; MISL PROTEIN; OVALBUMIN; OVALBUMIN CD4 PEPTIDE; UNCLASSIFIED DRUG; CD4 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HELPER CELL; MOUSE; NONHUMAN; SALMONELLA; WESTERN BLOTTING; ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; GENE EXPRESSION; IN VIVO STUDY; OUTER MEMBRANE; POLYMERIZATION; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ENTEROBACTERIACEAE; NEGIBACTERIA; SALMONELLA;

ANIMALS; ANTIGENS, CD4; BACTERIAL PROTEINS; CELL WALL; EPITOPES; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; PLASMIDS; RECOMBINANT FUSION PROTEINS; SALMONELLA; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84902291848     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-13-80     Document Type: Article

References (47)

1. Hagan CL, Silhavy TJ, Kahne D. beta-Barrel membrane protein assembly by the Bam complex. Annu Rev Biochem 2011, 80:189-210. 10.1146/annurev-biochem-061408-144611, 21370981.
2. Rossiter AE, Leyton DL, Tveen-Jensen K, Browning DF, Sevastsyanovich Y, Knowles TJ, Nichols KB, Cunningham AF, Overduin M, Schembri MA, Henderson IR. The essential beta-barrel assembly machinery complex components BamD and BamA are required for autotransporter biogenesis. J Bacteriol 2011, 193:4250-4253. 10.1128/JB.00192-11, 3147704, 21665980.
3. Grijpstra J, Arenas J, Rutten L, Tommassen J. Autotransporter secretion: varying on a theme. Res Microbiol 2013, 164:562-582. 10.1016/j.resmic.2013.03.010, 23567321.
4. Jong WS, Sauri A, Luirink J. Extracellular production of recombinant proteins using bacterial autotransporters. Curr Opin Biotechnol 2010, 21:646-652. 10.1016/j.copbio.2010.07.009, 20932460.
5. van Bloois E, Winter RT, Kolmar H, Fraaije MW. Decorating microbes: surface display of proteins on Escherichia coli. Trends Biotechnol 2011, 29:79-86. 10.1016/j.tibtech.2010.11.003, 21146237.
6. Dorsey CW, Laarakker MC, Humphries AD, Weening EH, Baumler AJ. Salmonella enterica serotype Typhimurium MisL is an intestinal colonization factor that binds fibronectin. Mol Microbiol 2005, 57:196-211. 10.1111/j.1365-2958.2005.04666.x, 15948960.
7. Ruiz-Perez F, Leon-Kempis R, Santiago-Machuca A, Ortega-Pierres G, Barry E, Levine M, Gonzalez-Bonilla C. Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL. Infect Immun 2002, 70:3611-3620. 10.1128/IAI.70.7.3611-3620.2002, 128084, 12065502.
8. Ruiz-Olvera P, Ruiz-Perez F, Sepulveda NV, Santiago-Machuca A, Maldonado-Rodriguez R, Garcia-Elorriaga G, Gonzalez-Bonilla C. Display and release of the Plasmodium falciparum circumsporozoite protein using the autotransporter MisL of Salmonella enterica. Plasmid 2003, 50:12-27. 10.1016/S0147-619X(03)00047-7, 12826054.
9. Alvarez AM, Vaquero-Vera A, Fonseca-Linan R, Ruiz-Perez F, Villegas-Sepulveda N, Ortega-Pierres G. A prime-boost vaccination of mice with attenuated Salmonella expressing a 30-mer peptide from the Trichinella spiralis gp43 antigen. Vet Parasitol 2013, 194:202-206. 10.1016/j.vetpar.2013.01.056, 23462251.
10. Chen H, Schifferli DM. Comparison of a fimbrial versus an autotransporter display system for viral epitopes on an attenuated Salmonella vaccine vector. Vaccine 2007, 25:1626-1633. 10.1016/j.vaccine.2006.11.006, 17169467.
11. Griffin AJ, McSorley SJ. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol 2011, 4:371-382. 10.1038/mi.2011.2, 21307847.
12. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001, 19:23-45. 10.1146/annurev.immunol.19.1.23, 11244029.
13. John B, Weninger W, Hunter CA. Advances in imaging the innate and adaptive immune response to Toxoplasma gondii. Future Microbiol 2010, 5:1321-1328. 10.2217/fmb.10.97, 3032660, 20860479.
14. Pepper M, Dzierszinski F, Crawford A, Hunter CA, Roos D. Development of a system to study CD4 + -T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect Immun 2004, 72:7240-7246. 10.1128/IAI.72.12.7240-7246.2004, 529136, 15557649.
15. Pape KA, Kearney ER, Khoruts A, Mondino A, Merica R, Chen ZM, Ingulli E, White J, Johnson JG, Jenkins MK. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol Rev 1997, 156:67-78. 10.1111/j.1600-065X.1997.tb00959.x, 9176700.
16. Chen ZM, Jenkins MK. Clonal expansion of antigen-specific CD4 T cells following infection with Salmonella typhimurium is similar in susceptible (Itys) and resistant (Ityr) BALB/c mice. Infect Immun 1999, 67:2025-2029. 96564, 10085054.
17. Ravindran R, McSorley SJ. Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology 2005, 114:450-458. 10.1111/j.1365-2567.2005.02140.x, 1782102, 15804280.
18. Bumann D. T cell receptor-transgenic mouse models for studying cellular immune responses to Salmonella in vivo. FEMS Immunol Med Microbiol 2003, 37:105-109. 10.1016/S0928-8244(03)00064-6, 12832113.
19. Londono LP, Chatfield S, Tindle RW, Herd K, Gao XM, Frazer I, Dougan G. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 1996, 14:545-552. 10.1016/0264-410X(95)00216-N, 8782354.
20. Chen H, Schifferli DM. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica Serovar Typhimurium vaccine strains. Infect Immun 2000, 68:3129-3139. 10.1128/IAI.68.6.3129-3139.2000, 97544, 10816454.
21. Oxer MD, Bentley CM, Doyle JG, Peakman TC, Charles IG, Makoff AJ. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic Acids Res 1991, 19:2889-2892. 10.1093/nar/19.11.2889, 328247, 2057350.
22. Galen JE, Curtiss R. The delicate balance in genetically engineering live vaccines. Vaccine 2013, published on line December 23, 2013; http://dx.doi.org/10.1016/j.vaccine.2013.12.026.
23. Galen JE, Wang JY, Chinchilla M, Vindurampulle C, Vogel JE, Levy H, Blackwelder WC, Pasetti MF, Levine MM. A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors. Infect Immun 2010, 78:337-347. 10.1128/IAI.00916-09, 2798174, 19884333.
24. Chen H, Schifferli DM. Construction, characterization and immunogenicity of an attenuated Salmonella enterica Serovar Typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter. Infect Immun 2003, 71:4664-4673. 10.1128/IAI.71.8.4664-4673.2003, 165986, 12874347.
25. Wick MJ, Pfeifer JD. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol 1996, 26:2790-2799. 10.1002/eji.1830261135, 8921970.
26. Carreno LJ, Bueno SM, Bull P, Nathenson SG, Kalergis AM. The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology 2007, 121:227-237. 10.1111/j.1365-2567.2007.02561.x, 2265936, 17313485.
27. Higgins DE, Shastri N, Portnoy DA. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol Microbiol 1999, 31:1631-1641. 10.1046/j.1365-2958.1999.01272.x, 10209738.
28. Pope C, Kim SK, Marzo A, Masopust D, Williams K, Jiang J, Shen H, Lefrancois L. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol 2001, 166:3402-3409. 10.4049/jimmunol.166.5.3402, 11207297.
29. Serre K, Mohr E, Toellner KM, Cunningham AF, Granjeaud S, Bird R, MacLennan IC. Molecular differences between the divergent responses of ovalbumin-specific CD4 T cells to alum-precipitated ovalbumin compared to ovalbumin expressed by Salmonella. Mol Immunol 2008, 45:3558-3566. 10.1016/j.molimm.2008.05.010, 18582945.
30. Barat S, Willer Y, Rizos K, Claudi B, Maze A, Schemmer AK, Kirchhoff D, Schmidt A, Burton N, Bumann D. Immunity to intracellular Salmonella depends on surface-associated antigens. PLoS Pathog 2012, 8:e1002966. 10.1371/journal.ppat.1002966, 3475680, 23093937.
31. Maskell DJ, Sweeney KJ, Callaghan D, Hormaeche CE, Liew FY, Dougan G. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathog 1987, 2:211-221. 10.1016/0882-4010(87)90022-2, 3333799.
32. Hone D, Attridge S, van den Bosch L, Hackett J. A chromosomal integration system for stabilization of heterologous gene in Salmonella based vaccine strains. Microb Pathog 1988, 5:407-418. 10.1016/0882-4010(88)90002-2, 2907600.
33. Froehlich BJ, Scott JR. A single-copy promoter-cloning vector for use in Escherichia coli. Gene 1991, 108:99-101. 10.1016/0378-1119(91)90492-T, 1761236.
34. McKelvie ND, Stratford R, Wu T, Bellaby T, Aldred E, Hughes NJ, Chatfield SN, Pickard D, Hale C, Dougan G, Khan SA. Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. Vaccine 2004, 22:3243-3255. 10.1016/j.vaccine.2004.05.014, 15308346.
35. Xu X, Husseiny MI, Goldwich A, Hensel M. Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines. Infect Immun 2010, 78:4828-4838. 10.1128/IAI.00298-10, 2976355, 20732994.
36. Saxena M, Coloe PJ, Smooker PM. Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine. Clin Vaccine Immunol 2009, 16:78-87. 10.1128/CVI.00253-08, 2620664, 19005022.
37. Bumann D. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses. Infect Immun 2001, 69:7493-7500. 10.1128/IAI.69.12.7493-7500.2001, 98839, 11705925.
38. Luria-Perez R, Cedillo-Barron L, Santos-Argumedo L, Ortiz-Navarrete VF, Ocana-Mondragon A, Gonzalez-Bonilla CR. A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope. Vaccine 2007, 25:5071-5085. 10.1016/j.vaccine.2007.03.047, 17543427.
39. Jose J, Meyer TF. The autodisplay story, from discovery to biotechnical and biomedical applications. Microbiol Mol Biol Rev 2007, 71:600-619. 10.1128/MMBR.00011-07, 2168652, 18063719.
40. Loeffler DI, Schoen CU, Goebel W, Pilgrim S. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes. Infect Immun 2006, 74:3946-3957. 10.1128/IAI.00112-06, 1489688, 16790768.
41. Hegazy WA, Xu X, Metelitsa L, Hensel M. Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens. Infect Immun 2012, 80:1193-1202. 10.1128/IAI.06056-11, 3294654, 22252866.
42. Hanahan D. Techniques for transformation of E. coli. DNA cloning: a practical approach 1985, 1:109-135. Oxford, UK: IRL Press, Glover DM.
43. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985, 33:103-119. 10.1016/0378-1119(85)90120-9, 2985470.
44. Hoiseth SK, Stocker BD. Aromatic-dependent Salmonella typhimurium are nonvirulent and effective as live vaccines. Nature 1981, 291:238-239. 10.1038/291238a0, 7015147.
45. Schödel F, Kelly SM, Peterson DL, Milich DR, Curtiss R. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun 1994, 62:1669-1676. 186381, 8168928.
46. Schifferli DM, Alrutz M. Permissive linker insertion sites in the outer membrane protein of 987P fimbriae of Escherichia coli. J Bacteriol 1994, 176:1099-1110. 205162, 7906265.
47. Achtman M, Manning PA, Edelbluth C, Herrlich P. Export without proteolytic processing of inner and outer membrane proteins encoded by F sex factor Tra cistrons in Escherichia coli minicells. Proc Natl Acad Sci USA 1979, 76:4837-4841. 10.1073/pnas.76.10.4837, 413032, 388418.